Chris Sale

Chris Sale is getting the anti-Strasburg treatment. And it tells us … nothing.

21 Comments

Jeff Passan talks with Chris Sale and the White Sox. While Stephen Strasburg was shut down at 159 and a third, the White Sox’ young arm is still going at 188.  No, Sale never had Tommy John surgery, but he had also never thrown more than 71 innings before this season.

It’s an interesting article, but not because it tells us which approach is right and which approach is wrong with a young starter. Indeed, try this little experiment: Read Passan’s article and check out the quotes from Don Cooper and everyone with the White Sox.  Then imagine a future where Sale is facing Tommy John surgery or worse and think how horribly they’ll play. Heck, they’ll be used at a capital trial of those pitching war criminals.  Do the same for Strasburg in relation to all of the cautious quotes from the Nats and their fans if Strasburg nonetheless gets hurt. Now reverse it, with both guys being healthy. You can take any and every possible lesson from it depending on the outcome.

The most interesting thing about it all is just how certain the White Sox are that they’re doing the right thing with Sale.  And how, earlier, the Nationals were just as certain that they were doing the right thing with Strasburg.  Sort of tells you that, no, no one has any freakin’ idea what the right thing is, the only validation, such as it is, that anyone will get is if either of those two get injured in the future, and even then we won’t know whether their treatment caused it, prevented it, was meaningless or not.

Report: Marlins intent on adding a big-three reliever

CHICAGO, IL - JULY 28:  Aroldis Chapman #54 of the Chicago Cubs pitches in the 9th inning against the Chicago Cubs at Wrigley Field on July 28, 2016 in Chicago, Illinois. The Cubs defeated the White Sox 3-1.  (Photo by Jonathan Daniel/Getty Images)
Jonathan Daniel/Getty Images
Leave a comment

The Marlins are intent on adding one of the three best relievers available on the free agent market, Jon Heyman of FanRag Sports reports. Those three, of course, are Aroldis Chapman, Kenley Jansen, and Mark Melancon.

As Ashley noted earlier, Melancon is reportedly fielding multiple four-year offers in excess of $60 million. The price tags for Chapman and Jansen are likely to match or exceed that. The Marlins haven’t typically been eager to whip out the checkbook for free agents but with the bullpen being the name of the game in baseball these days, GM Michael Hill may feel the need to match his rivals.

The Nationals, Giants, Yankees, Cubs, and Dodgers are the teams most often linked to the “big-three” group of relievers, so it won’t be easy for the Marlins.

A.J. Ramos handled the closer’s role for the Marlins this past season and did an admirable job, saving 40 games with a 2.81 ERA and a 73/35 K/BB ratio in 64 innings. There’s no doubt, though, that Chapman, Jansen, or Melancon would represent a significant upgrade in the ninth inning.

Bryan Price likely to use Raisel Iglesias, Tony Cingrani, and Michael Lorenzen in closer’s role

Cincinnati Reds starting pitcher Raisel Iglesias throws in the first inning of their opening day baseball game against the Philadelphia Phillies, Monday, April 4, 2016, in Cincinnati. (AP Photo/John Minchillo)
AP Photo/John Minchillo
Leave a comment

C. Trent Rosecrans of the Cincinnati Enquirer reports that Reds manager Bryan Price is likely going to use a trio of pitchers in the closer’s role: Raisel Iglesias, Tony Cingrani, and Michael Lorenzen. At RedsFest on Saturday, Price said:

I’d say right now that we have a series of guys that I’m comfortable with in the ninth inning and that would include (Raisel) Iglesias, (Tony) Cingrani and (Michael Lorenzen). Should we stay with this format – which I intend to do – all three of those guys and maybe more could have opportunities in save situations. At this point in time, there’s no defined closer. There are multiple options and I’d like to stick with the philosophy that we’re going to have our multi-inning guys, so we’re going to need multi-closers.

This seems to be part of the new bullpen zeitgeist in which managers are shying away from strictly-defined roles for their relievers. Indians manager Terry Francona’s postseason success using Andrew Miller likely had some degree of influence on Price’s willingness to go with a three-headed giant.

Iglesias started the 2016 season in the Reds’ rotation but missed two months with an injury, then moved to the bullpen in late June. Price put him in the closer’s role down the stretch in September. The right-hander overall finished the season with a 2.53 ERA and an 83/26 K/BB ratio in 78 1/3 innings.

Cingrani battled control issues in his 63 innings of work this past season, finishing with a 4.14 ERA and a 49/37 K/BB ratio. He’s left-handed, though, and gives Price some matchup flexibility in the late innings.

Lorenzen impressed in his first full season as a reliever, ending the year with a 2.88 ERA and a 48/13 K/BB ratio in 50 innings. The right-hander uses a fastball that sits around 96 MPH on average along with a cutter and slider.